Coronado, Gloria D.
Kihn-Stang, Alexandra
Slaughter, Matthew T.
Petrik, Amanda F.
Thompson, Jamie H.
Rivelli, Jennifer S.
Jimenez, Ricardo
Gibbs, Jeffrey
Yadav, Neha
Mummadi, Rajasekhara R.
Funding for this research was provided by:
foundation for the national institutes of health (R01CA218923)
Article History
Received: 14 July 2021
Accepted: 14 September 2021
First Online: 28 September 2021
Declarations
:
: The study was reviewed by the Kaiser Permanente Northwest Institutional Review Board [protocol # STUDY00000779]; the study was granted a waiver of informed consent because it posed minimal risks to patients. Thus, no written nor verbal consent was obtained.
: Not applicable.
: From September 2017–June 2018, GDC served as the Principal Investigator on an industry funded study (Quidel Corporation) to compare the clinical performance of an experimental FIT to an FDA-approved FIT. In 2020–2021, GDC served as a scientific advisor for Exact Sciences and Guardant Health. All other authors declare no conflicts of interest.